Back to Authors

Ansell, Stephen M.

https://orcid.org/0000-0003-1244-6758

A5059729547 | I1330342723

Mayo Clinic

Citations 952

Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1742-1744

10.1182/blood-2022-159620

Secreted Sars-Cov-2 Encoded ORF8 Protein Stimulates Pro-Inflammatory Cytokines and Predicts Severe Clinical Outcome

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 42-43

10.1182/blood-2022-162574

IRF4 Shapes the Tumor Microenvironment of Follicular Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 168-169

10.1182/blood-2022-157408

Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6489-6491

10.1182/blood-2022-167633

Exploratory Analysis of Factors Influencing Efficacy and Safety of Camidanlumab Tesirine: Data from the Open-Label, Multicenter, Phase 2 Study of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3673-3677

10.1182/blood-2022-157583

Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10942-10944

10.1182/blood-2022-164785

Prevalence and Impact of Clonal Hematopoiesis in Therapy Related Myeloid Neoplasms Occurring in the Context of Low-Grade Follicular Lymphoma Treated with Radioisotope Therapy

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11403-11405

10.1182/blood-2022-165124

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3548-3550

10.1182/blood-2022-170228

Waldenstrom Macroglobulinemia and the Clinical Implications of Acquired Von Willebrand Syndrome

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9363-9365

10.1182/blood-2022-168232

Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2399-2401

10.1182/blood-2022-167187